Improving the Outcome for Anti-GD2 mAb-based Immunotherapy of High-risk Neuroblastoma: Less Toxicity and Greater Efficacy
Paul Sondel, MD, PhD
Professor, Department of Human Oncology
University of Wisconsin-Madison
Visiting Professor: Paul Sondel, MD, PhD
This event has passed.
WIMR 3001A and Zoom
@ 12:15 pm - 1:15 pm